Delivery Order SPE2DE21D7001-SPE2D625F45AM

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $5.7K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Spring Lake Park, MN 55432, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,875.65, was issued by the Defense Health Agency (DHA) to Medtronic Inc., a global leader in medical technology, through its Medtronic USA, Inc. division. The contract is for the supply of a Biologics - DBM-TS-OTI Grafton DBM Matrix product, which is a surgical implant used in various medical procedures. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of June 12, 2024. Medtronic is the prime...
The U.S. government has awarded a $5,702.85 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of Biologics - DBM-TS-OTI Grafton DBM Matrix medical products. This contract was awarded by the Defense Health Agency (DHA), a component of the Department of Defense (DoD) that oversees the Military Health System. The contract has an ultimate completion date of December 9, 2024 and does not have a set-aside designation. Medtronic is a...
The U.S. government agency the Defense Health Agency (DHA) awarded a $2,875.65 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical products. This contract does not have a set-aside designation. Medtronic is a global leader in medical technology, specializing in developing and manufacturing innovative medical devices and therapies. As a major supplier...
The federal contract award SPE2DE21D7001|SPE2D624F5LU2 was issued by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,875.65 fixed-price delivery order is for the procurement of Grafton Demineralized Bone Matrix (DBM) tissue matrix products, which are advanced surgical implants used in various medical procedures. Medtronic, a global leader in medical technologies, has been awarded this contract...
The U.S. government agency, the Defense Health Agency (DHA), awarded a $1,516.20 fixed-price with economic price adjustment delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, to provide biologics - DBM-TS-GRAFTON DBF. This contract has an ultimate completion date of October 15, 2024. Medtronic is a global medical technology company that specializes in developing and manufacturing innovative medical devices and therapies. The company has a significant...
This is a $1,590.30 fixed-price with economic price adjustment delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., a global medical technology company, through its Medtronic USA, Inc. division. The contract is for the procurement of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRI, a type of surgical implant, with a period of performance ending on November 14, 2024. The award is not designated as a set-aside contract. Medtronic is a major supplier of advanced medical devices and...
This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Medtronic Inc., a global medical technology company. The $12,350 fixed-price delivery order is for the procurement of BIOLOGICS - DBM-TS-MAGNIFUSE DBM medical supplies. The contract has an ultimate completion date of March 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) framework between Medtronic and the Department of Veterans Affairs valued at up to $600 million for...
The U.S. government has awarded a $3,790.50 fixed-price delivery order contract to Medtronic Inc., through its Medtronic USA, Inc. division, for the supply of BIOLOGICS - DBM-TS-GRAFTON DBF medical products. This contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense. The contract has no set-aside designation and runs through July 10, 2024. Medtronic is a global leader in medical technology, providing a wide range of innovative medical devices and...
This federal contract award, with an ID of SPE2DE21D7001|SPE2D625F10G7, was issued by the Defense Health Agency (DHA) to Medtronic Inc. through its Medtronic USA, Inc. division. The $2,875.65 fixed-price contract, with economic price adjustment, is for the delivery of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical supplies. Medtronic is a global leader in medical technology, specializing in innovative medical devices and therapies. As a major supplier to the federal government, Medtronic...
This federal contract award, SPE2DE21D7001|SPE2D625F75RV, was made by the Defense Health Agency (DHA) to Medtronic Inc. for the delivery of BIOLOGICS - DBM-TS-OTI GRAFTON DBM MATRIX medical supplies. The contract is a Delivery Order with a Firm Fixed Price with Economic Price Adjustment pricing type and has a ceiling value of $1,900.95. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Medtronic Inc., a global leader in medical...
  • SPE2DE21D7001
    Indefinite Delivery Contract
  • SPE2DE21D7001-SPE2D625F45AM
    Delivery Order

This federal contract award, valued at $5,702.85, was issued by the Defense Health Agency (DHA) to the prime contractor Medtronic Inc. The contract is a fixed-price delivery order with an economic price adjustment, and the ultimate completion date is January 28, 2025. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Medtronic Inc., a global leader in medical technology, will provide biologics - specifically, a Grafton DBM Matrix - to support the DHA's medical supply needs. This award is part of Medtronic's broader Indefinite Delivery Contract (IDC) valued at up to $600 million with the Department of Veterans Affairs for providing surgical implants and related products through December 2028. Additionally, Medtronic holds a single-award IDC with the DHA for maintenance and repair services of the Medtronic Stealth System at the Madigan Army Medical Center, with a ceiling value of $160,000.

Generated 4/28/25, 9:48 AM